X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35) 35
humans (33) 33
infectious diseases (27) 27
hiv infections - drug therapy (23) 23
maraviroc (23) 23
adult (22) 22
male (21) 21
female (19) 19
middle aged (19) 19
hiv (18) 18
immunology (18) 18
cyclohexanes - therapeutic use (16) 16
triazoles - therapeutic use (16) 16
pharmacology & pharmacy (15) 15
virology (13) 13
aged (12) 12
anti-hiv agents - therapeutic use (12) 12
hiv infections - virology (12) 12
adolescent (11) 11
aids/hiv (11) 11
ccr5 (11) 11
cyclohexanes - adverse effects (11) 11
hiv-1 - drug effects (11) 11
human immunodeficiency virus--hiv (11) 11
infection (11) 11
triazoles - adverse effects (11) 11
viral load (11) 11
cyclohexanes - administration & dosage (10) 10
hiv fusion inhibitors - therapeutic use (10) 10
hiv-1 - genetics (10) 10
treatment outcome (10) 10
triazoles - administration & dosage (10) 10
antiretroviral drugs (9) 9
hiv-1 (9) 9
hiv-1 - physiology (9) 9
pharmacokinetics (9) 9
young adult (9) 9
cyclohexanes - pharmacology (8) 8
drug therapy (8) 8
treatment-experienced patients (8) 8
triazoles - pharmacology (8) 8
double-blind method (7) 7
genotype (7) 7
microbiology (7) 7
tropism (7) 7
anti-hiv agents - administration & dosage (6) 6
anti-hiv agents - adverse effects (6) 6
assay (6) 6
ccr5 antagonist (6) 6
ccr5 receptor antagonists (6) 6
cd4 lymphocyte count (6) 6
efavirenz (6) 6
efficacy (6) 6
hiv infection (6) 6
immunodeficiency-virus type-1 (6) 6
receptors, ccr5 - metabolism (6) 6
antiretroviral therapy (5) 5
antiviral agents (5) 5
clinical trials (5) 5
clinical-trials (5) 5
combination (5) 5
coreceptor usage (5) 5
cyclohexanes - pharmacokinetics (5) 5
drug therapy, combination (5) 5
hiv fusion inhibitors - adverse effects (5) 5
hiv infections - complications (5) 5
hiv infections - immunology (5) 5
research (5) 5
ribonucleic acid--rna (5) 5
rna (5) 5
safety (5) 5
therapy (5) 5
triazoles - pharmacokinetics (5) 5
viral tropism (5) 5
viruses (5) 5
algorithms (4) 4
benzoxazines - therapeutic use (4) 4
clinical science (4) 4
dosage and administration (4) 4
emtricitabine (4) 4
high-throughput nucleotide sequencing (4) 4
hiv envelope protein gp120 - genetics (4) 4
hiv-1 infection (4) 4
hiv-1-infected patients (4) 4
hiv/aids (4) 4
individuals (4) 4
inhibitor (4) 4
r5 hiv-1 infection (4) 4
tenofovir (4) 4
trial (4) 4
tropisms (4) 4
viral tropism - genetics (4) 4
virus diseases (4) 4
anti-hiv agents - pharmacology (3) 3
care and treatment (3) 3
case-control studies (3) 3
clinical trials as topic (3) 3
coinfection (3) 3
coreceptor tropism (3) 3
darunavir (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Infectious Diseases, ISSN 0022-1899, 3/2010, Volume 201, Issue 6, pp. 803 - 813
Background. The MERIT (M̄araviroc versus Ēfavir̄enz īn T̄reatment-Naive Patients) study compared maraviroc and efavirenz, both with zidovudine-lamivudine, in... 
HIV/AIDS | Tropisms | RNA | HIV | Stock options | Response rates | Viruses | Infections | Post hoc | HIV 1 | Virology | INFECTIOUS DISEASES | EFFICACY | SAFETY | MICROBIOLOGY | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | LOPINAVIR-RITONAVIR | THERAPY | VIROLOGICAL FAILURE | RESISTANT HIV-1 | INHIBITOR | CORECEPTOR TROPISM | PLUS | Anti-HIV Agents - pharmacology | Lamivudine - administration & dosage | Cyclohexanes - pharmacology | Humans | Middle Aged | Drug Resistance, Viral | Male | Anti-HIV Agents - standards | Viral Load | Zidovudine - administration & dosage | Young Adult | Cyclohexanes - therapeutic use | Receptors, CCR5 - metabolism | HIV-1 - physiology | Adult | Female | Triazoles - standards | Viral Tropism | Drug Therapy, Combination | CCR5 Receptor Antagonists | Triazoles - therapeutic use | Antiviral Agents - pharmacology | Double-Blind Method | HIV-1 - drug effects | Treatment Outcome | Anti-Retroviral Agents | Benzoxazines - standards | Benzoxazines - therapeutic use | Triazoles - pharmacology | Adolescent | Benzoxazines - pharmacology | Cyclohexanes - standards | HIV Infections - drug therapy | Aged | Drug Combinations | Maraviroc | Patient outcomes | Physiological aspects | Dosage and administration | Genetic aspects | Research | Drug therapy, Combination | Drug therapy | HIV infection | Efavirenz | Chemokines | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 1/2011, Volume 203, Issue 2, pp. 237 - 245
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 10, pp. e13188 - e13188
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 12/2010, Volume 55, Issue 5, pp. 558 - 564
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 05/2015, Volume 43, Issue 5, pp. 771 - 772
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 06/2015, Volume 1346, Issue 1, pp. 7 - 17
Journal Article
Journal Article
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 02/2013, Volume 62, Issue 2, pp. 164 - 170
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 11, pp. 1659 - 1666
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 11/2012, Volume 61, Issue 3, pp. 279 - 286
Journal Article
Journal Article